12:00 AM
 | 
Dec 23, 2002
 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Corixa Corp.

(CRXA), Seattle, Wash.

Business: Cancer, Autoimmune/Inflammation

SG Cowen analyst Philip Nadeau lowered his 2004 revenue estimate for...

Read the full 91 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >